past, present, and future management strategies for non-transfusion dependent β-thalassemia
Published 1 year ago • 147 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
8:38
treating transfusion dependent and independent beta-thalassemia, and believe/beyond trial updates
-
1:10
current and emerging therapeutic strategies in beta-thalassemia
-
2:18
a global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
-
1:34
personalizing treatment of transfusion-dependent anemia in lr-mds
-
3:38
looking to the future in the treatment of beta thalassemia
-
0:54
study design for persist-2 and other upcoming trials of pacritinib
-
1:00:10
master class lecture on "management of thalassemia" 24th august 2022
-
8:21
thalassemia major home treatment | thalassemia major
-
7:08
believe: β-thalassemia treatment with luspatercept reduces transfusion burden
-
57:25
transfusion decisions
-
1:25
the current approach to managing patients with prefibrotic pmf
-
18:51
healthcare reform and hematology – the value of a laboratory and pathology utilization program
-
2:35
long-term results of the believe study: luspatercept in patients with beta-thalassemia
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
2:12
revolutionary approaches for thalassemia
-
2:17
extended follow-up of the master trial
-
0:36
versiti diagnostic labs | hematology
-
2:41
an overview of the latest advances in hematology
-
1:22
what will the future haematology workforce look like?
-
2:36
mypath™ for health: the next generation of patient engagement solutions
-
2:20
quantifying the anemia benefit of momelotinib in mf: analysis of data from simplify-1 & simplify-2
-
1:08
the progress of the ebmt & key ongoing projects